Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
Titel:
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
Auteur:
Abou-Alfa, G.K. Qin, S. Ryoo, B.-Y. Lu, S.-N. Yen, C.-J. Feng, Y.-H. Lim, H.Y. Izzo, F. Colombo, M. Sarker, D. Bolondi, L. Vaccaro, G. Harris, W.P. Chen, Z. Hubner, R.A. Meyer, T. Sun, W. Harding, J.J. Hollywood, E.M. Ma, J. Wan, P.J. Ly, M. Bomalaski, J. Johnston, A. Lin, C.-C. Chao, Y. Chen, L.-T.